Affiliation:
1. Department of Pharmacy Practice, Grace College of Pharmacy, Palakkad, Kerala, India.
Abstract
Background: Chronic kidney disease is a major public health issue which requires complex pharmacotherapy. This study was aimed to evaluate drug utilization pattern in chronic kidney disease patients. Method: A prospective observational study was conducted at Nephrology department in Rajiv Gandhi Cooperative Multispecialty hospital, Palakkad for a period of 6 month from July 2022 to January 2023. Medications were assessed by using WHO prescribing indicator and classified in the basis of Anatomic Therapeutic Classification. Results: A total of 120 patients were examined. According to the ATC categorization, out of a total of 921 medicines, cardiovascular drugs were most frequently administered. The average number of drugs per prescription was 7.6%. 11.3% of those medications were prescribed by their generic names. 49.9% of drugs were prescribed on the accordance with essential medicine list. The patient prescribed with an injection was 46% and patients prescribed with antibiotic were 25.5%. Poly pharmacy was executed in 86% of patients. Antihypertensive drugs were most frequently recommended class of drugs followed by hematopoietic drugs and vitamin and minerals in therapeutic wise classification of drugs. Conclusion: Of all drugs prescribed, cardiovascular drugs were commonly prescribed and prevalence of poly pharmacy is high in patients due to co morbidities.
Publisher
Oriental Scientific Publishing Company
Subject
Drug Discovery,Agronomy and Crop Science,Biotechnology
Reference24 articles.
1. ]. Lv JC, Zhang Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol.2019;1165:3-15. DOI: 1007/978-981-13-8871-2_1. PMID: 31399958
2. Nipun Shrestha, Sanju Gautham. Burden of chronic kidney disease in the general population ang high-risk groups in South Asia: A systematic review and meta analysis.Chronic kidney disease in South Asia.2021;22(11):1- DOI: 10.1371/journal.pone.0258494. PMID: 34648578. PMCID: PMC8516300
3. C.H.Moideen KuttyGurukkal, B K Bithun. Co-morbidities and their management in patients with chronic kidney disease in a tertiary hospital of International Journal of Scientific Study.2018;6(1):151-154.
4. Changrong Ke , Juanjuan Liang , Mi Liu , Shiwei Liu. Burden of chronic kidney disease and its risk- attributable burden in 137 low-and middle-income countries, 1990–2019: results from the global burden of disease study BMC Nephrology.2022;23(17):1-12. doi: 10.1186/s12882-021-02597-3.PMID: 34986789
5. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis.PLOS ONE.2016;11(7):1-18. PMID: 27383068